Keld Flintholm Jørgensen
Directeur/Bestuurslid bij SCANDION ONCOLOGY A/S
Profiel
Keld Flintholm Jørgensen is currently an Independent Director at Scandion Oncology A since 2022 and a Senior VP & Head-Business Development at H.
Lundbeck A since 2019.
Previously, he worked as a Director-Strategic Partnering at Roche Pharma (Schweiz) AG.
He has an undergraduate and graduate degree from Copenhagen Business School.
Actieve functies van Keld Flintholm Jørgensen
| Bedrijven | Functie | Begin |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 04-04-2019 |
| SCANDION ONCOLOGY A/S | Directeur/Bestuurslid | 01-04-2022 |
Eerdere bekende functies van Keld Flintholm Jørgensen
| Bedrijven | Functie | Einde |
|---|---|---|
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Corporate Officer/Principal | - |
Opleiding van Keld Flintholm Jørgensen
| Copenhagen Business School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Distribution Services |
